Skip to content
PICO Portalanswers from OpenAlex

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

PaperCitations, authors & open-access status

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study is a paper indexed in PICO Portal from OpenAlex.

How many citations does Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study have?

PICO Portalcitation count

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study has 411 citations in the OpenAlex counts PICO Portal stores.

When was Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study published?

PICO Portalyear

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study has 2015 year in the PICO Portal index.

What is the open-access status of Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study?

PICO Portaloa status

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study has closed oa status in the PICO Portal index.

What is the DOI of Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study?

PICO Portaldoi

The DOI for Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study is on the source record.

What is the PMID of Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study?

PICO Portalpmid

The PMID for Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study is on the source record.

What is the OpenAlex record for Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study?

PICO Portalopenalex

The OpenAlex for Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial